Sunday, December 1, 2019

Prostate cancer 'super responders' live for 2 years on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown. Researchers found that a small proportion of men were 'super responders' and were alive and well even after the trial had ended despite having had a very poor prognosis before treatment.

from Top Health News -- ScienceDaily https://ift.tt/37WTi6f

No comments:

Post a Comment

These fat-filled brain cells may be making multiple sclerosis worse

Scientists have uncovered a surprising clue that may help explain why multiple sclerosis (MS) progresses rapidly in some people but not othe...